Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

scPharmaceuticals Q2 EPS $(0.34) Misses $(0.30) Estimate, Sales $16.041M Beat $15.413M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:04pm
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 14.09 percent. This is a 22.73 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $16.041 million which beat the analyst consensus estimate of $15.413 million by 4.07 percent. This is a 99.17 percent increase over sales of $8.054 million the same period last year.

Posted In: SCPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist